Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer.

Gordian, Edna

Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer. [electronic resource] - PloS one 2014 - e114131 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1932-6203

10.1371/journal.pone.0114131 doi


Aniline Compounds--metabolism
Antineoplastic Agents--metabolism
Antineoplastic Combined Chemotherapy Protocols
Apoptosis--drug effects
Carcinoma, Non-Small-Cell Lung--pathology
Cell Line, Tumor
Dasatinib
Drug Resistance, Neoplasm
Humans
Intracellular Space--drug effects
Lung Neoplasms--pathology
Molecular Docking Simulation
Nitriles--metabolism
Protein Conformation
Protein Serine-Threonine Kinases--chemistry
Pyrimidines--metabolism
Quinolines--metabolism
Receptor, Transforming Growth Factor-beta Type I
Receptors, Transforming Growth Factor beta--chemistry
Signal Transduction--drug effects
Smad3 Protein--metabolism
Thiazoles--metabolism
Transforming Growth Factor beta--metabolism